prosapient limited

Live YoungLargeRapid

prosapient limited Company Information

Share PROSAPIENT LIMITED

Company Number

10704431

Shareholders

nominee of smedvig capital xv lp

margaryta polishchuk

View All

Group Structure

View All

Industry

Market research and public opinion polling

 

Registered Address

floor 5 33 holborn, london, EC1N 2HT

prosapient limited Estimated Valuation

£23.2m

Pomanda estimates the enterprise value of PROSAPIENT LIMITED at £23.2m based on a Turnover of £28.3m and 0.82x industry multiple (adjusted for size and gross margin).

prosapient limited Estimated Valuation

£0

Pomanda estimates the enterprise value of PROSAPIENT LIMITED at £0 based on an EBITDA of £-2m and a 4.82x industry multiple (adjusted for size and gross margin).

prosapient limited Estimated Valuation

£10.4m

Pomanda estimates the enterprise value of PROSAPIENT LIMITED at £10.4m based on Net Assets of £6.4m and 1.64x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Prosapient Limited Overview

Prosapient Limited is a live company located in london, EC1N 2HT with a Companies House number of 10704431. It operates in the market research and public opinion polling sector, SIC Code 73200. Founded in April 2017, it's largest shareholder is nominee of smedvig capital xv lp with a 19.6% stake. Prosapient Limited is a young, large sized company, Pomanda has estimated its turnover at £28.3m with rapid growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Prosapient Limited Health Check

Pomanda's financial health check has awarded Prosapient Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating4.5out of 5
positive_score

6 Strong

positive_score

2 Regular

positive_score

3 Weak

size

Size

annual sales of £28.3m, make it larger than the average company (£9.8m)

£28.3m - Prosapient Limited

£9.8m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 54%, show it is growing at a faster rate (6.3%)

54% - Prosapient Limited

6.3% - Industry AVG

production

Production

with a gross margin of 62.7%, this company has a comparable cost of product (60.2%)

62.7% - Prosapient Limited

60.2% - Industry AVG

profitability

Profitability

an operating margin of -14.3% make it less profitable than the average company (6%)

-14.3% - Prosapient Limited

6% - Industry AVG

employees

Employees

with 244 employees, this is above the industry average (60)

244 - Prosapient Limited

60 - Industry AVG

paystructure

Pay Structure

on an average salary of £60.1k, the company has an equivalent pay structure (£65.5k)

£60.1k - Prosapient Limited

£65.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £115.9k, this is less efficient (£152.2k)

£115.9k - Prosapient Limited

£152.2k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 36 days, this is earlier than average (68 days)

36 days - Prosapient Limited

68 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 14 days, this is quicker than average (34 days)

14 days - Prosapient Limited

34 days - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Prosapient Limited

- - Industry AVG

cashbalance

Cash Balance

has cash to cover current liabilities for 34 weeks, this is more cash available to meet short term requirements (12 weeks)

34 weeks - Prosapient Limited

12 weeks - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 54.3%, this is a lower level of debt than the average (61.8%)

54.3% - Prosapient Limited

61.8% - Industry AVG

PROSAPIENT LIMITED financials

EXPORTms excel logo

Prosapient Limited's latest turnover from December 2023 is £28.3 million and the company has net assets of £6.4 million. According to their latest financial statements, Prosapient Limited has 244 employees and maintains cash reserves of £3.2 million as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Aug 2019Aug 2018
Turnover28,289,61729,383,64719,947,8887,790,0005,524,0592,966,836608,474
Other Income Or Grants
Cost Of Sales10,539,38011,664,0557,761,8933,115,9302,324,5691,161,712238,955
Gross Profit17,750,23717,719,59212,185,9954,674,0703,199,4901,805,124369,519
Admin Expenses21,786,84019,738,31813,869,2785,699,1015,234,2033,029,427763,860
Operating Profit-4,036,603-2,018,726-1,683,283-1,025,031-2,034,713-1,224,303-394,341
Interest Payable71,4993,772
Interest Receivable7,2668,7553,101
Pre-Tax Profit-4,108,102-2,022,498-1,683,283-1,025,031-2,027,447-1,215,548-391,240
Tax118,744-42,511-22,296-46,605
Profit After Tax-3,989,358-2,065,009-1,705,579-1,071,636-2,027,447-1,215,548-391,240
Dividends Paid
Retained Profit-3,989,358-2,065,009-1,705,579-1,071,636-2,027,447-1,215,548-391,240
Employee Costs14,668,92516,863,39510,536,2554,559,3533,455,6882,072,467380,797
Number Of Employees2442421556859377
EBITDA*-2,025,664-1,041,966-1,222,585-920,728-2,003,625-1,190,264-341,370

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Aug 2019Aug 2018
Tangible Assets298,634324,116296,641152,799208,923215,47014,319
Intangible Assets4,803,5134,614,4782,954,9181,145,730
Investments & Other88
Debtors (Due After 1 year)214,358208,000208,000208,000
Total Fixed Assets5,102,1474,938,5943,465,9171,506,529416,931423,47814,319
Stock & work in progress
Trade Debtors2,865,8483,081,5382,722,1531,319,144822,637439,992107,679
Group Debtors13,55812,647
Misc Debtors2,694,0943,113,1662,370,2891,875,373757,725909,30649,993
Cash3,232,8142,021,1281,332,9205,713,2811,110,6031,507,680826,921
misc current assets
total current assets8,792,7568,215,8326,425,3628,907,7982,704,5232,869,625984,593
total assets13,894,90313,154,4269,891,27910,414,3273,121,4543,293,103998,912
Bank overdraft
Bank loan
Trade Creditors 407,403481,023851,010144,723163,139177,363782
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities4,435,9972,495,0301,811,0382,123,8121,232,360890,750122,844
total current liabilities4,843,4002,976,0532,662,0482,268,5351,395,4991,068,113123,626
loans1,500,000
hp & lease commitments
Accruals and Deferred Income
other liabilities63,88290,778
provisions1,196,4531,321,453918,211367,822125,000125,000
total long term liabilities2,696,4531,321,453918,211367,822188,882215,778
total liabilities7,539,8534,297,5063,580,2592,636,3571,584,3811,283,891123,626
net assets6,355,0508,856,9206,311,0207,777,9701,537,0732,009,212875,286
total shareholders funds6,355,0508,856,9206,311,0207,777,9701,537,0732,009,212875,286
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Aug 2019Aug 2018
Operating Activities
Operating Profit-4,036,603-2,018,726-1,683,283-1,025,031-2,034,713-1,224,303-394,341
Depreciation152,492128,740143,11294,26531,08834,0391,122
Amortisation1,858,447848,020317,58610,03851,849
Tax118,744-42,511-22,296-46,605
Stock
Debtors-634,762887,9041,904,2831,600,5971,644,2481,412,273157,672
Creditors-73,620-369,987706,287-18,416162,357176,581782
Accruals and Deferred Income1,940,967683,992-312,774891,4521,109,516767,906122,844
Deferred Taxes & Provisions-125,000403,242550,389242,822125,000125,000
Cash flow from operations470,189-1,255,134-2,205,262-1,452,072-2,251,000-1,533,050-375,416
Investing Activities
capital expenditure-225,692-235,190-67,290
Change in Investments-888
cash flow from investments8-225,700-235,198-67,290
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans1,500,000
Hire Purchase and Lease Commitments
other long term liabilities-63,88263,88290,778
share issue1,487,4884,610,909238,6297,312,5332,689,2342,349,4741,266,526
interest-71,499-3,7727,2668,7553,101
cash flow from financing2,915,9894,607,137238,6297,248,6512,760,3822,449,0071,269,627
cash and cash equivalents
cash1,211,686688,208-4,380,3614,602,678283,682680,759826,921
overdraft
change in cash1,211,686688,208-4,380,3614,602,678283,682680,759826,921

prosapient limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for prosapient limited. Get real-time insights into prosapient limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Prosapient Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for prosapient limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other large companies, companies in EC1N area or any other competitors across 12 key performance metrics.

prosapient limited Ownership

PROSAPIENT LIMITED group structure

Prosapient Limited has no subsidiary companies.

Ultimate parent company

PROSAPIENT LIMITED

10704431

PROSAPIENT LIMITED Shareholders

nominee of smedvig capital xv lp 19.61%
margaryta polishchuk 16.84%
jordan shlosberg 16.79%
24 haymarket nominees limited 11.21%
stephen john holliday 3.08%
christian thum 2.91%
guy hands 1.97%
oliver hanff 1.54%
stuart thomas 1.43%
stefan weiss 1.31%

prosapient limited directors

Prosapient Limited currently has 8 directors. The longest serving directors include Miss Margaryta Polishchuk (Apr 2017) and Mr Thomas Hoppe (Jun 2019).

officercountryagestartendrole
Miss Margaryta PolishchukUnited Kingdom36 years Apr 2017- Director
Mr Thomas HoppeUnited Kingdom66 years Jun 2019- Director
Mr Stephen HollidayEngland46 years Aug 2019- Director
Mr Stephen HollidayUnited Kingdom46 years Aug 2019- Director
Mr Robert TomsUnited Kingdom63 years Dec 2020- Director
Mr Robert TomsUnited Kingdom63 years Dec 2020- Director
Dr Christopher Potts68 years Nov 2023- Director
Mr Aneil RakityUnited Kingdom51 years Jan 2024- Director

P&L

December 2023

turnover

28.3m

-4%

operating profit

-4m

+100%

gross margin

62.8%

+4.05%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

6.4m

-0.28%

total assets

13.9m

+0.06%

cash

3.2m

+0.6%

net assets

Total assets minus all liabilities

prosapient limited company details

company number

10704431

Type

Private limited with Share Capital

industry

73200 - Market research and public opinion polling

incorporation date

April 2017

age

8

incorporated

UK

ultimate parent company

None

accounts

Group

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

MOORE KINGSTON SMITH LLP

address

floor 5 33 holborn, london, EC1N 2HT

Bank

-

Legal Advisor

-

prosapient limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to prosapient limited. Currently there are 1 open charges and 3 have been satisfied in the past.

prosapient limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PROSAPIENT LIMITED. This can take several minutes, an email will notify you when this has completed.

prosapient limited Companies House Filings - See Documents

datedescriptionview/download